NCT07842666Not yet recruiting
Baveno VIII Criteria for Portal Hypertension in Egyptian Patients
Cost-Effectiveness and Validation of Baveno VIII Criteria for Detecting Clinically Significant Portal Hypertension in Egyptian Patients With Compensated Advanced Chronic Liver Disease
Source: ClinicalTrials.gov · Last updated 25 Sept 2026
Brief summary (registry, in English)
This prospective observational study aims to validate Baveno VIII criteria for detection of clinically significant portal hypertension and to evaluate additional predictors of esophageal varices in Egyptian patients with compensated advanced chronic liver disease and liver stiffness measurement between 15 and 25 kPa.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 125 (estimated)
- First submitted
- 21 Sept 2026
- Start date
- 26 Sept 2026
- Primary completion date
- 26 Sept 2027
- Lead sponsor
- Assiut University
- Diseases
- High blood pressure
- NCT number
- NCT07842666
What you commit to
- Study type: Observational
- Planned participants: 125
- From 26 Sept 2026 to the primary completion date, 26 Sept 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- \- Previous variceal bleeding or band ligation
- Concurrent viral hepatitis and MASLD
Other illness
- TIPS, hepatocellular carcinoma, or portal vein thrombosis
- Acute liver failure
Other
- Overt hepatic encephalopathy
- Severe ascites affecting LSM reliability
- Pregnancy or refusal to undergo endoscopy
Who the study is looking for
- \- Age 18 years or older
- Compensated advanced chronic liver disease (cACLD)
- Liver stiffness measurement by VCTE under fasting conditions
- Liver stiffness measurement between 15 and 25 kPa
- Eligible for upper gastrointestinal endoscopy
- Written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.